Jiangyong Yu
5PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 13, 2025
A Multi-Center Real-World Study of Clinicopathologic Characteristics and Efficacy of the Malignant Mesothelioma in Chinese Population.Chenrui Sun, Xue Yang, Lan Chen
|Oct 14, 2024
Efficacy and safety of immunotherapy combined with chemotherapy in patients with ES-SCLC: A systematic review and network meta-analysis of RCTs and RWSs.Runting Kang, Junling Ma, Bin Ai
|Dec 14, 2023
Advances in new targets for immunotherapy of small cell lung cancer.Zitong Zheng, Juanjuan Liu, Junling Ma
|Jul 27, 2022
TP53 and LRP1B Co-Wild Predicts Improved Survival for Patients with LUSC Receiving Anti-PD-L1 Immunotherapy.Jiangyong Yu, Zaiwen Fan, Zhipeng Zhou
|Jun 23, 2022
Whole exome analysis reveals the genomic profiling related to chemo-resistance in Chinese population with limited-disease small cell lung cancer.Jiangyong Yu, Shuangtao Zhao, Zhe Su
Pageof 1
